Dermatology Modifier 25: Same-Day E/M Documentation

Identify work beyond the minor procedure

Modifier 25 addresses a significant, separately identifiable evaluation and management service performed on the same day as a procedure or other qualifying service. It does not turn routine procedural assessment into a separate office visit. In dermatology, examining a lesion, deciding to perform a minor procedure, obtaining consent, and providing routine procedure instructions may be part of the procedure's usual work. The practical question is what additional evaluation and management occurred beyond that work. CMS specifically reminds dermatologists that E/M services are generally included with minor surgical procedures unless a significant, separately identifiable E/M service was performed. 1

Document the independent clinical assessment

A useful record identifies the additional problem assessment, relevant findings, management decisions, and follow-up plan. For example, medication management for an inflammatory condition may represent work distinct from treatment of an unrelated lesion, but its reportability depends on what was actually done and documented. A second diagnosis alone is not evidence of a separate service. Conversely, the same diagnosis does not automatically prevent separate reporting. The record should allow a reviewer to distinguish the E/M reasoning from the procedure description without counting headings or relying on a statement that modifier 25 applies. Separate note sections can improve clarity, but their presence does not establish medical necessity.

Keep E/M level selection independent

Once a separate E/M service is supported, select its level under the applicable E/M rules. Do not increase the visit level simply because a procedure occurred or the appointment lasted longer. If using time, exclude separately reported procedural time and follow the applicable service's time requirements. If using medical decision-making, assess the documented problems, data, and management risk without automatically treating the procedure as support for a higher level. CMS NCCI also explains that a new patient is not entitled to a separately reportable E/M service merely because the patient is new. The same substantive separation test applies. 2

Hypothetical scenario: medication review plus destruction

A patient returns for an inadequately controlled inflammatory skin condition. The dermatologist reviews response and adverse effects, changes the prescription regimen, and establishes monitoring and follow-up. During the same encounter, the clinician also destroys a separately identified lesion. The signed record clearly distinguishes the condition-management work from the lesion procedure. A coder evaluates whether that independent E/M service meets modifier 25 criteria and selects the level from the supported work. By contrast, if the visit had consisted only of assessing the lesion, choosing destruction, obtaining consent, and giving routine aftercare, adding a separately titled office-visit paragraph would not create an additional billable E/M service.

Checklist for a defensible modifier decision

Make modifier review a clinical-documentation decision rather than an automatic response to a claim edit. The reviewer should be able to describe the separate E/M work in ordinary language before approving the modifier. When that description is impossible, obtain clarification or remove unsupported reporting. Preserve the underlying note and any dated clarification so the submitted claim remains traceable to the encounter rather than to an insurer's rejection message.

• Identify the procedure and the assessment ordinarily included in its payment.
• Describe the significant E/M work that remains after procedural work is excluded.
• Confirm that the documented E/M level is independently supported.
• Attach modifier 25 to the E/M service when appropriate, not to the procedure.
• Review global-period issues and payer instructions before releasing the claim.

Coding cautions and payer variations

Modifier 25 is not interchangeable with modifier 57, which addresses the decision for major surgery in the applicable circumstances, or modifier 24 for qualifying unrelated postoperative E/M services. Check the actual global indicator instead of assuming every dermatology operation is minor. Medicare policy does not require different diagnoses for the separate E/M and minor procedure, but payer claim-processing policies may require additional documentation or apply their own review procedures. Verify those policies rather than inventing a universal separate-note rule. If a payer denies the E/M, distinguish a documentation request from a finding that the service was not separately identifiable before deciding whether correction, reconsideration, or appeal is appropriate.

Audit the reasoning, then seek targeted support

A useful internal audit reviews both submitted and omitted modifier 25 services. Overuse can produce unsupported claims, while overly broad suppression can hide genuinely separate care. Group findings by cause: routine procedural work billed as E/M, unsupported level selection, missing management detail, or confusion about a postoperative period. Discuss representative examples with clinicians using the actual record instead of a modifier-frequency target. Cyber Sense can help a dermatology practice map these findings to a practical prebilling review. Request a consultation focused on the practice's services, payer mix, and documentation workflow; no modifier policy can responsibly guarantee payment for every same-day encounter.

Frequently asked questions

Related articles

• Dermatology Biopsy Documentation: Technique and Site
• Lesion Destruction vs Excision: Dermatology Coding
• Dermatology Repair Coding: Complexity and Measurements